medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2010, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2010; 62 (1)


Propiedades métricas de instrumentos de disfunción no motora en enfermedad de Parkinson en población mexicana

Cervantes-Arriaga A, Rodríguez-Violante M, Villar-Velarde A, López-Gómez M, Teresa-Corona

Idioma: Español
Referencias bibliográficas: 28
Paginas: 8-14
Archivo PDF: 65.70 Kb.


RESUMEN

Objetivo. Determinar las propiedades métricas de los instrumentos clinimétricos cuestionario de síntomas no motores (NMSQuest), escala de síntomas no motores (NMSS) y SCOPA- AUT para la evaluación de síntomas no motores en la enfermedad de Parkinson en población mexicana. Material y métodos: Previa validación lingüística se aplicaron los instrumentos a 100 pacientes consecutivos con enfermedad de Parkinson que acuden al Instituto Nacional de Neurología y Neurocirugía. Se analizó la información para validación de los instrumentos incluyendo consistencia interna, variabilidad inter-observador y correlaciones intra-clase. Resultados. La consistencia interna mediante alfa de Cronbach fue superior a 0.80 en todos los casos; las correlaciones inter-ítem e ítem-dominio en su mayoría fueron mayores de 0.30. La variabilidad inter-observador fue aceptable. El puntaje de los instrumentos no correlaciono de forma significativa con otras variables clínicas. Discusión. Las propiedades métricas de los instrumentos estudiados son aceptables siendo similares a las publicadas en otros países.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson´s disease: diagnosis and management. Lancet Neurol 2006; 5: 235-45.

  2. Gulati A, Forbes A, Stegie F, Kelly L, Clough C, Chaudhauri KR. A clinical observational study of the pattern and ocurrence of non-motor symproms in Parkinson’s disease ranging from early to advanced disease. Mov Disord 2004; 19(Suppl. 9): S406.

  3. O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira- Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 2007; 23: 101-06.

  4. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkisnon’s disease: frequent and disabling. Neurology 2002; 59: 408-13.

  5. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 2008; 23: 1420-07.

  6. Chaudhuri KR, Naidu Y. Early Parkinson’s disease and nonmotor issues. J Neurol 2008; 255(Suppl. 5): 33-8.

  7. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003; 24: 197-210.

  8. Chaudhuri KR, Yates L, Martínez-Martín P. The non-motor symptom complex of Parkinson’s disease. A comprenhensive assesement is essential. Curr Neurol Neurosci Rep 2005; 5: 275-83.

  9. Chaudhuri KR, Marínez-Martin P. Quantification of non-motor symptoms in Parkinson’s disease. Eur J Neurol 2008; 15(Suppl. 2): 2-7.

  10. Chaudhuri KR, Martínez-Martin P, Schapira AHV, Stocchi F, Sethi K, et al. International multicenter pilot study of the first comprehensive slef-completed nonmotor symptoms questionnaire for Parkinson’s disease: The NMSQuest Study. Mov Disord 2006; 7: 916-23.

  11. Chaudhuri KR, Martínez-Martin P, Brown RG, Sethi K, Stocchi F, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Result from an international pilot study. Mov Disord 2007; 13: 1901-11.

  12. Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assesment of autonomic dysfunction in Parkinson´s disease: The SCOPAAUT. Mov Disord 2004; 11: 1306-12.

  13. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patientreported outcomes (PRO) measures: report of the ISPOR task force for translating adaptation. Value Health 2005; 2: 94-104.

  14. Gibb WRG, Lees AJ. The relevance of Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-52.

  15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.

  16. Kulisevsky J, Pagonbarraga J. Cognitive impairment in Parkinson’s diseas: tools for diagnosis and assessment. Mov Disord 2009; 24: 1103-10.

  17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-42.

  18. McHorney TA, Tarlov AR. Individual-patient monitoring in clinical practice: are avaliable health status surveys adequate? Qual Life Res 1995; 4: 293-307.

  19. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441-9.

  20. Guyatt GH, Berman LB, Townsend M, Pugsley SO, CHambers LW. A measure of quality of life in clinical trials in chronic lung disease. Thorax 1987; 42: 773-8.

  21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-92.

  22. Jamnadas-Khoda J, Koshy S, Mathias CJ, Muthan UB, Ragothaman M, Dodaballapur SK. Are current recommendations to diagnose orthostatic hypotension in Parkinson’s disease satisfactory? Mov Disord 2009; Early View. DOI. 10.1002/ mds.22537.

  23. Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009; 16: 174-82.

  24. Silveira-Moriyama L, Carvalho MD, Katzenschlager R, et al. The use of smell identification tests in the diagnosis of Parkinson’s disease in Brazil. Mov Disord 2008; 23: 2328-34.

  25. Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, et al. Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2007; 22: 1077-92.

  26. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23: 2015-25.

  27. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23: 2004-14.

  28. Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, et al. Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23: 484-500.




2020     |     www.medigraphic.com